Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11685746 Heteroaryl compounds for treating Huntington's disease

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
PTC Therapeutics, Inc.
PTC Therapeutics, Inc.
0
Date Filed
June 25, 2019
0
Date of Patent
June 27, 2023
0
Patent Applicant
PTC Therapeutics, Inc.
PTC Therapeutics, Inc.
0
Patent Application Number
17254848
0
Patent Citations
‌
US Patent 7910578 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
0
‌
US Patent 8314119 Azaadamantane derivatives and methods of use
0
‌
US Patent 8563550 Imidazolothiadiazoles for use as protein kinase inhibitors
0
‌
US Patent 8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
0
‌
US Patent 9399649 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9371336 Compounds for treating spinal muscular atrophy
0
‌
US Patent 7326711 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
0
‌
US Patent 7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
0
‌
US Patent 7569337 Coumarines useful as biomarkers
0
‌
US Patent 7655657 Fused bicycloheterocycle substituted quinuclidine derivatives
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11685746
0
Patent Primary Examiner
‌
Kahsay Habte
0
CPC Code
‌
C07D 513/04
0
‌
C07D 519/00
0

Find more entities like US Patent 11685746 Heteroaryl compounds for treating Huntington's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo